Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
from Featured Health News from Medical News Today http://bit.ly/2JWn956
https://ift.tt/2zMU3B8
May 23, 2019
|
Labels:
Featured Health News from Medical News Today
|
This entry was posted on May 23, 2019
and is filed under
Featured Health News from Medical News Today
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.